The U.S. Food and Drug Administration approved GlaxoSmithKline Plc’s Tanzeum™ injection for treating adults with type 2 diabetes, in combination with diet and exercise … more

The FDA also approved GSK’s Arzerra® for certain patients with chronic lymphocytic leukemia … more

— UPCOMING EVENTS —

4/29 4:00 pm – 6:00 pm in New Haven
Yale & CURE BioHaven presents ‘Melinta Therapeutics: The Road from the Lab to New Medicines’ more

5/12 5:00 pm – 6:30 pm in New Haven
BioScienceClubhouseCT presents ‘SystaMedic: A Novel Cause-Effect Analysis Platform for Predicting Probability of R&D Program Success.’  more